NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sartorius Stedim Biotech S.A (PA: DIM)

 
DIM Technical Analysis
4
As on 30th May 2025 DIM STOCK Price closed @ 194.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 205.42 & Strong Sell for SHORT-TERM with Stoploss of 242.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DIMSTOCK Price

Open 192.30 Change Price %
High 195.15 1 Day 1.25 0.65
Low 191.60 1 Week -4.25 -2.14
Close 194.00 1 Month 21.10 12.20
Volume 110225 1 Year -49.00 -20.16
52 Week High 280.00 | 52 Week Low 145.35
 
PA France Most Active Stocks
ALCYB 0.00 %
ALEUP 0.01 0.00%
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALVER 0.00 %
TTE 51.66 0.49%
ALALO 0.00 %
VIE 30.28 0.77%
ORA 13.13 -0.15%
CA 13.16 -7.52%
 
PA France Top Gainers Stocks
ALMAR 0.74 51.02%
ALCHI 0.13 44.44%
ALKLK 1.06 37.66%
MLAAH 0.04 33.33%
ALAMA 0.24 20.00%
MLHOT 52.50 18.24%
ALENT 6.12 15.47%
ALDEV 11.70 12.50%
2MX 7.46 8.43%
ALSPW 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
FPG 0.06 -14.29%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
MLSDN 26.60 -10.74%
ALINT 0.59 -10.61%
ELEC 142.00 -8.39%
ELEC 142.00 -8.39%
 
 
DIM
Daily Charts
DIM
Intraday Charts
Whats New @
Bazaartrend
DIM
Free Analysis
 
DIM Important Levels Intraday
RESISTANCE200.84
RESISTANCE198.65
RESISTANCE197.29
RESISTANCE195.93
SUPPORT192.07
SUPPORT190.71
SUPPORT189.35
SUPPORT187.16
 
DIM Forecast June 2025
4th UP Forecast265.68
3rd UP Forecast242.69
2nd UP Forecast228.48
1st UP Forecast214.27
1st DOWN Forecast173.73
2nd DOWN Forecast159.52
3rd DOWN Forecast145.31
4th DOWN Forecast122.32
 
DIM Weekly Forecast
4th UP Forecast223.48
3rd UP Forecast214.03
2nd UP Forecast208.18
1st UP Forecast202.34
1st DOWN Forecast185.66
2nd DOWN Forecast179.82
3rd DOWN Forecast173.97
4th DOWN Forecast164.52
 
DIM Forecast2025
4th UP Forecast467.44
3rd UP Forecast379.75
2nd UP Forecast325.54
1st UP Forecast271.34
1st DOWN Forecast116.66
2nd DOWN Forecast62.46
3rd DOWN Forecast8.25
4th DOWN Forecast-79.44
 
 
DIM Other Details
Segment EQ
Market Capital 43451432960.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
DIM Address
DIM
 
DIM Latest News
 
Your Comments and Response on Sartorius Stedim Biotech S.A
 
DIM Business Profile
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. Address: Zone Industrielle Les Paluds, Aubagne, France, 13781
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service